{"id":"https://openalex.org/W2107948728","doi":"https://doi.org/10.1517/14656560902765769","title":"InforMatrix for attention deficit hyperactivity disorder","display_name":"InforMatrix for attention deficit hyperactivity disorder","publication_year":2009,"publication_date":"2009-04-01","ids":{"openalex":"https://openalex.org/W2107948728","doi":"https://doi.org/10.1517/14656560902765769","mag":"2107948728","pmid":"https://pubmed.ncbi.nlm.nih.gov/19351226"},"language":"en","primary_location":{"id":"doi:10.1517/14656560902765769","doi":"https://doi.org/10.1517/14656560902765769","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14656560902765769","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035811371","display_name":"Robert Janknegt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166163","display_name":"Maaslandziekenhuis","ror":"https://ror.org/04cm78a24","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210166163"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Robert Janknegt","raw_affiliation_strings":["Hospital Pharmacist, Clinical Pharmacologist Maasland Ziekenhuis, Postbus, Sittard, The Netherlands. r.janknegt@orbisconcern.nl","+31 464597971","Hospital Pharmacist, Clinical Pharmacologist Maasland Ziekenhuis, Postbus 5500, 6130 MB Sittard, The Netherlands +31 46 4597709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Pharmacist, Clinical Pharmacologist Maasland Ziekenhuis, Postbus, Sittard, The Netherlands. r.janknegt@orbisconcern.nl","institution_ids":["https://openalex.org/I4210166163"]},{"raw_affiliation_string":"+31 464597971","institution_ids":[]},{"raw_affiliation_string":"Hospital Pharmacist, Clinical Pharmacologist Maasland Ziekenhuis, Postbus 5500, 6130 MB Sittard, The Netherlands +31 46 4597709","institution_ids":["https://openalex.org/I4210166163"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043257215","display_name":"Adrianne Faber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149686","display_name":"SIR Institute for Pharmacy Practice and Policy","ror":"https://ror.org/04prjvw86","country_code":"NL","type":"other","lineage":["https://openalex.org/I4210149686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Adrianne Faber","raw_affiliation_strings":["SIR Institute for Pharmacy Practice and Policy, Theda Mansholtstraat 5b, 2331 JE Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SIR Institute for Pharmacy Practice and Policy, Theda Mansholtstraat 5b, 2331 JE Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210149686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023343277","display_name":"Rob Rodrigues Pereira","orcid":"https://orcid.org/0000-0003-0212-9011","observed_orcids":["https://orcid.org/0000-0003-0212-9011"]},"institutions":[{"id":"https://openalex.org/I4210108903","display_name":"Maasstad Ziekenhuis","ror":"https://ror.org/01n0rnc91","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210108903"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Rob Rodrigues Pereira","raw_affiliation_strings":["Maasstad ziekenhuis, locatie Zuiderziekenhuis, Groene Hilledijk 315, 3075 EA Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maasstad ziekenhuis, locatie Zuiderziekenhuis, Groene Hilledijk 315, 3075 EA Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210108903"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042903151","display_name":"Luuk J. Kalverdijk","orcid":"https://orcid.org/0000-0002-7908-1282","observed_orcids":["https://orcid.org/0000-0002-7908-1282"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Luuk J Kalverdijk","raw_affiliation_strings":["University Medical Center Groningen, Department of Psychiatry, P.O. Box 660, 9700 AR Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center Groningen, Department of Psychiatry, P.O. Box 660, 9700 AR Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1772,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.59740032,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"5","first_page":"755","last_page":"772"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9980000257492065},{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.9860000014305115},{"id":"https://openalex.org/keywords/concerta","display_name":"Concerta","score":0.9869999885559082},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.6320000290870667},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.9330000281333923},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.47699999809265137},{"id":"https://openalex.org/keywords/ease-of-use","display_name":"ease of use","score":0.5080000162124634}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.983612060546875},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.960604727268219},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8968031406402588},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.722093939781189},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.5484876036643982},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5210254192352295},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.48234862089157104},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.44725728034973145},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34986716508865356},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.24840474128723145},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10296493768692017}],"mesh":[{"descriptor_ui":"D000069445","descriptor_name":"Atomoxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009426","descriptor_name":"Netherlands","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1517/14656560902765769","doi":"https://doi.org/10.1517/14656560902765769","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14656560902765769","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:19351226","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19351226","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on pharmacotherapy","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/3022ba43-e6a0-4bbb-aec6-688c964dbef0","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/3022ba43-e6a0-4bbb-aec6-688c964dbef0","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Janknegt, R, Faber, A, Pereira, R R & Kalverdijk, L J 2009, 'InforMatrix for attention deficit hyperactivity disorder', Expert Opinion on Pharmacotherapy, vol. 10, no. 5, pp. 755-772. https://doi.org/10.1517/14656560902765769","raw_type":"info:eu-repo/semantics/publishedVersion"},{"id":"pmh:rug:oai:pure.rug.nl:publications/3022ba43-e6a0-4bbb-aec6-688c964dbef0","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/3022ba43-e6a0-4bbb-aec6-688c964dbef0","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"EXPERT OPINION ON PHARMACOTHERAPY, 10(5), 755 - 772. TAYLOR & FRANCIS LTD","raw_type":"info:eu-repo/semantics/other"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":101,"referenced_works":["https://openalex.org/W7049542","https://openalex.org/W58893836","https://openalex.org/W71528383","https://openalex.org/W73658022","https://openalex.org/W88422652","https://openalex.org/W123597899","https://openalex.org/W167078310","https://openalex.org/W261265812","https://openalex.org/W1586258382","https://openalex.org/W1965946834","https://openalex.org/W1967288147","https://openalex.org/W1967768276","https://openalex.org/W1968714336","https://openalex.org/W1968752176","https://openalex.org/W1970031540","https://openalex.org/W1973632776","https://openalex.org/W1978755811","https://openalex.org/W1979160725","https://openalex.org/W1979177892","https://openalex.org/W1981109961","https://openalex.org/W1993327116","https://openalex.org/W1995097711","https://openalex.org/W1995484354","https://openalex.org/W1996091936","https://openalex.org/W1999037665","https://openalex.org/W1999662659","https://openalex.org/W2007567296","https://openalex.org/W2013667607","https://openalex.org/W2016483680","https://openalex.org/W2018129806","https://openalex.org/W2018410082","https://openalex.org/W2020147842","https://openalex.org/W2022977833","https://openalex.org/W2023169310","https://openalex.org/W2027823632","https://openalex.org/W2027974893","https://openalex.org/W2033200028","https://openalex.org/W2033428561","https://openalex.org/W2039748755","https://openalex.org/W2040513075","https://openalex.org/W2044253418","https://openalex.org/W2045859644","https://openalex.org/W2048434346","https://openalex.org/W2048481057","https://openalex.org/W2048588916","https://openalex.org/W2050698601","https://openalex.org/W2050880665","https://openalex.org/W2051791048","https://openalex.org/W2054134161","https://openalex.org/W2056151789","https://openalex.org/W2060379497","https://openalex.org/W2060976026","https://openalex.org/W2062714266","https://openalex.org/W2063286745","https://openalex.org/W2066201328","https://openalex.org/W2068852148","https://openalex.org/W2074521517","https://openalex.org/W2082060645","https://openalex.org/W2088606503","https://openalex.org/W2094270069","https://openalex.org/W2095382166","https://openalex.org/W2101565436","https://openalex.org/W2101917725","https://openalex.org/W2103591380","https://openalex.org/W2108685959","https://openalex.org/W2108866348","https://openalex.org/W2109376915","https://openalex.org/W2112484680","https://openalex.org/W2113181557","https://openalex.org/W2115751971","https://openalex.org/W2117062136","https://openalex.org/W2120948822","https://openalex.org/W2122518346","https://openalex.org/W2123001448","https://openalex.org/W2123980944","https://openalex.org/W2124594192","https://openalex.org/W2127294790","https://openalex.org/W2128074636","https://openalex.org/W2131342243","https://openalex.org/W2132443852","https://openalex.org/W2142349212","https://openalex.org/W2148978240","https://openalex.org/W2151391760","https://openalex.org/W2155880922","https://openalex.org/W2156937504","https://openalex.org/W2161354465","https://openalex.org/W2162908443","https://openalex.org/W2164676183","https://openalex.org/W2166506167","https://openalex.org/W2166577179","https://openalex.org/W2167875798","https://openalex.org/W2285134444","https://openalex.org/W2315833978","https://openalex.org/W2335556316","https://openalex.org/W2400966861","https://openalex.org/W2409349312","https://openalex.org/W2419058229","https://openalex.org/W2419632642","https://openalex.org/W2601578636","https://openalex.org/W4241931919","https://openalex.org/W4247130871"],"related_works":["https://openalex.org/W2165990772","https://openalex.org/W2540796133","https://openalex.org/W2066232148","https://openalex.org/W2095079440","https://openalex.org/W99757118","https://openalex.org/W2038601354","https://openalex.org/W2570082249","https://openalex.org/W2531524018","https://openalex.org/W2005280126","https://openalex.org/W1787563038"],"abstract_inverted_index":{"The":[0,29,44,60,149,163,184],"purpose":[1],"of":[2,15,55,80,90,151,153,166,174,202,209,218],"this":[3],"review":[4],"is":[5,120,156,169,179,187],"to":[6,34,37,197],"facilitate":[7],"discussion":[8],"on":[9,215],"drug":[10],"selection":[11,22,46,204],"for":[12,63,159],"the":[13,66,71,115,147,160,175,180,195,200,203,207,216,226],"treatment":[14],"ADHD":[16,64],"by":[17],"using":[18],"only":[19],"clinically":[20],"relevant":[21,107],"criteria":[23,47,205],"and":[24,58,77,85,94,123,136,206],"providing":[25],"an":[26,190],"up-to-date":[27],"overview.":[28],"InforMatrix":[30,185],"method":[31],"was":[32,100],"used":[33],"select":[35],"drugs":[36,61],"treat":[38],"attention":[39],"deficit":[40],"hyperactivity":[41],"disorder":[42],"(ADHD).":[43],"following":[45],"were":[48,68,109,141],"applied:":[49],"clinical":[50,116],"efficacy,":[51],"safety,":[52],"tolerability,":[53],"ease":[54,150],"use,":[56],"applicability,":[57],"cost.":[59],"approved":[62],"in":[65,70,111,143,189],"Netherlands":[67],"included":[69],"analysis,":[72],"namely:":[73],"atomoxetine,":[74],"immediate-release":[75,154,167],"methylphenidate,":[76],"various":[78],"formulations":[79],"slow-release":[81,176],"methylphenidate":[82,155,168],"(Concerta,":[83],"Equasym":[84,135],"Medikinet).":[86],"Most":[87],"studies":[88,130],"are":[89],"limited":[91,122],"quality,":[92],"duration,":[93],"size.":[95],"In":[96],"one":[97],"study,":[98],"Concerta":[99],"more":[101],"effective":[102],"than":[103,158,172],"atomoxetine.":[104],"Although":[105],"no":[106],"differences":[108,140],"seen":[110,142],"other":[112,161],"comparative":[113],"studies,":[114],"experience":[117],"with":[118,134],"atomoxetine":[119],"still":[121],"unexpected":[124],"toxicity":[125],"cannot":[126],"be":[127],"excluded;":[128],"few":[129],"have":[131],"been":[132],"published":[133],"Medikinet.":[137],"No":[138],"major":[139],"general":[144],"tolerability":[145],"between":[146],"drugs.":[148,162],"use":[152],"less":[157],"acquisition":[164],"cost":[165],"considerably":[170],"lower":[171],"that":[173],"formulations.":[177],"Atomoxetine":[178],"most":[181],"expensive":[182],"drug.":[183],"program":[186],"available":[188],"interactive":[191],"format.":[192],"It":[193],"enables":[194],"user":[196],"judge":[198],"both":[199],"importance":[201],"properties":[208],"each":[210],"therapeutic":[211],"option":[212],"per":[213],"criterion":[214],"basis":[217],"his":[219],"or":[220],"her":[221],"own":[222],"personal":[223],"expertise":[224],"and/or":[225],"present":[227],"document.":[228]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}